Document Detail


Inclusion of 10% fish oil in mixed medium-chain triacylglycerol-long-chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids.
MedLine Citation:
PMID:  18689362     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Lipolysis of a fish oil (FO) emulsion is much slower than that of a soybean [long-chain triacylglycerol (LCT)] emulsion; in contrast, emulsions containing medium-chain triacylglycerol (MCT) are efficiently hydrolyzed by lipoprotein lipase. OBJECTIVES: We questioned whether incorporating 10% FO in a mixed MCT-LCT emulsion would affect plasma triacylglycerol clearance and provide efficient delivery of n-3 polyunsaturated fatty acids to cells and tissues. DESIGN: This prospective crossover study was conducted in 8 normolipidemic subjects with the use of the hypertriglyceridemic clamp model and compared plasma triacylglycerol clearance of a lipid emulsion (5:4:1) made of 50% MCT, 40% LCT, and 10% FO (wt:wt:wt) to a control (5:5) preparation with 50% MCT and 50% LCT. Subjects were daily infused for 5 h, over 4 consecutive days. Fatty acyl pattern was daily measured in plasma phospholipids as well as in leukocyte and platelet phospholipids. RESULTS: Inclusion of 10% FO in mixed emulsion particles enhanced plasma clearance of infused triacylglycerols (18%; P < 0.0001). The faster elimination of the 5:4:1 emulsion appears related to an enhanced uptake of remnant particles rather than to faster intravascular lipolysis. Each infusion of 5:4:1 raised the eicosapentaenoic acid (C20:5n-3) concentration in blood cell phospholipids to reach a 7-fold enrichment in platelets and a >2-fold enrichment in leukocytes after 4 infusions. In contrast, the docosahexaenoic acid (C22:6n-3) concentration remained unchanged in blood cell phospholipids. CONCLUSIONS: Infusion of a mixed emulsion with MCTs, soy LCTs, and FO is associated with efficient plasma triacylglycerol clearance and results in rapid incorporation of C20:5n-3 but not C22:6n-3 in leukocyte and platelet phospholipids.
Authors:
Christian M Simoens; Richard J Deckelbaum; Jacques J Massaut; Yvon A Carpentier
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  88     ISSN:  1938-3207     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-11     Completed Date:  2008-09-12     Revised Date:  2009-05-15    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  282-8     Citation Subset:  AIM; IM    
Affiliation:
L Deloyers Laboratory for Experimental Surgery, Université Libre de Bruxelles, Brussels, Belgium and the Intensive Care Unit, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Platelets / chemistry,  metabolism
Cross-Over Studies
Dose-Response Relationship, Drug
Eicosapentaenoic Acid / metabolism*
Fat Emulsions, Intravenous* / chemistry
Fish Oils / administration & dosage*
Humans
Leukocytes / chemistry,  metabolism
Liver / metabolism
Male
Metabolic Clearance Rate
Parenteral Nutrition
Phospholipids / chemistry,  metabolism*
Prospective Studies
Triglycerides / blood,  metabolism,  pharmacokinetics*
Grant Support
ID/Acronym/Agency:
HL40404/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Fat Emulsions, Intravenous; 0/Fish Oils; 0/Phospholipids; 0/Triglycerides; 1553-41-9/Eicosapentaenoic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that inv...
Next Document:  Food patterns and cardiovascular disease risk factors: the Swedish INTERGENE research program.